Centre Hospitalo-Universitaire La Timone – Assistance Publique des Hôpitaux de Marseille

Flag of

  |    secretariat.pr.attarian@ap-hm.fr

The Center for Neuromuscular Diseases and ALS  situated in La Timone University Hospital in Marseille consists of several units, each dedicated to a specific field of neuromuscular diseases.

These areas are:

  • Acquired and hereditary neuropathies
  • Myopathies
  • Neuromuscular junction diseases
  • Amyotrophic lateral sclerosis and motor neuron diseases
  • Electroneuromyography

Professor Shahram ATTARIAN, Head of Department, coordinates the healthcare centers of Marseille, Nice, Reunion Island, Lyon, Grenoble, Saint-Etienne and Clermont-Ferrand.

HCP representation

Prof Shahram Attarian MD, PhD

    +33491386579

Head of referenece center for neuromusculars disorders ans ALS Coordinator of reference centers of PACA- Réunion-Rhôn-Alpes (Marseille , Lyon, Nice, Saint Etienne , Reunion island) MD, PhD

Location

Centre Hospitalo-Universitaire La Timone – Assistance Publique des Hôpitaux de Marseille

264 Rue Saint Pierre Service de Neurologie des Maladies Neuromusculaires et SLA
9eme Étage, Marseille 13005
France

Group membership

Centre Hospitalo-Universitaire La Timone – Assistance Publique des Hôpitaux de Marseille participates in the following groups…

Specialised Groups
Muscle diseases
Peripheral Nerve Disease
Motor Neuron Disease
Neuromuscular Junction Defects
Mitochondrial Diseases

Cross Cutting Specialised Groups
Neuromuscular Imaging
Neurophysiology
Neuromuscular Pathology
Genetics

Advisory Boards
Ethics
Research
Education
Centre Hospitalo-Universitaire La Timone – Assistance Publique des Hôpitaux de Marseille is registered with the Care and Trial Site Registry

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern“